Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100346515 | 10034651 | 5 | F | 200504 | 20160817 | 20140325 | 20160822 | EXP | US-PFIZER INC-2014077700 | PFIZER | 49.00 | YR | F | Y | 78.00000 | KG | 20160822 | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100346515 | 10034651 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, DAILY | U | 20702 | 10 | MG | FILM-COATED TABLET | ||||||
| 100346515 | 10034651 | 2 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 20 MG, DAILY | U | 20702 | 20 | MG | FILM-COATED TABLET | ||||||
| 100346515 | 10034651 | 3 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 40 MG, DAILY | U | 20702 | 40 | MG | FILM-COATED TABLET | ||||||
| 100346515 | 10034651 | 4 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 80 MG, DAILY | U | 20702 | 80 | MG | FILM-COATED TABLET | ||||||
| 100346515 | 10034651 | 5 | C | DILTIAZEM. | DILTIAZEM | 1 | 120 MG, UNK | 0 | 120 | MG | |||||||||
| 100346515 | 10034651 | 6 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | 75 MG, UNK | 0 | 75 | MG | |||||||||
| 100346515 | 10034651 | 7 | C | NITROGLYCERIN. | NITROGLYCERIN | 1 | UNK | 0 | TRANSDERMAL PATCH |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100346515 | 10034651 | 1 | Low density lipoprotein increased |
| 100346515 | 10034651 | 2 | Cardiovascular event prophylaxis |
| 100346515 | 10034651 | 3 | Blood cholesterol increased |
| 100346515 | 10034651 | 5 | Cardiac disorder |
| 100346515 | 10034651 | 6 | Cardiac disorder |
| 100346515 | 10034651 | 7 | Cardiac disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100346515 | 10034651 | OT |
| 100346515 | 10034651 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100346515 | 10034651 | Cardiac disorder | |
| 100346515 | 10034651 | Hypertension | |
| 100346515 | 10034651 | Muscle spasms | |
| 100346515 | 10034651 | Myocardial infarction | |
| 100346515 | 10034651 | Type 2 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100346515 | 10034651 | 1 | 1997 | 200304 | 0 | |
| 100346515 | 10034651 | 2 | 200304 | 200406 | 0 | |
| 100346515 | 10034651 | 3 | 200406 | 200504 | 0 | |
| 100346515 | 10034651 | 4 | 200504 | 200612 | 0 | |
| 100346515 | 10034651 | 5 | 2003 | 0 | ||
| 100346515 | 10034651 | 6 | 2003 | 2010 | 0 | |
| 100346515 | 10034651 | 7 | 2003 | 2010 | 0 |